Company Information
CIN
Status
Date of Incorporation
11 July 1986
State / ROC
Mumbai / ROC Mumbai
Last Balance Sheet
31 March 2019
Last Annual Meeting
08 July 2019
Paid Up Capital
181,928,440
Authorised Capital
200,000,000
Directors
Gopakumar G Nair
Director/Designated Partner
over 2 years ago
over 2 years ago
Krishna Datla Vasantkumar
Director/Designated Partner
over 2 years ago
over 2 years ago
Varadvinayak Vijay Khambete
Company Secretary
almost 9 years ago
almost 9 years ago
Prashant Prabhakar Nagre
Manager/Secretary
about 12 years ago
about 12 years ago
Past Directors
Tirunelveli Padmanabhan Devarajan
Alternate Director
over 14 years ago
over 14 years ago
Viswanath Chebrol
Director
almost 15 years ago
almost 15 years ago
Peter John Bains
Director
about 15 years ago
about 15 years ago
Sanjay Buch Ramakant
Additional Director
almost 16 years ago
almost 16 years ago
Ranabir Shivaji Sanyal
Company Secretary
about 16 years ago
about 16 years ago
Anupama Datla Desai
Director
about 18 years ago
about 18 years ago
Satish Varma Azad Nadimpally
Director
about 21 years ago
about 21 years ago
Irfan Rafik Bandukwalla
Director
over 22 years ago
over 22 years ago
Govind Guno Desai
Director
almost 39 years ago
almost 39 years ago
Patents
The present invention discloses isolation of Penicillin Acylase (PA) from Achromobacter sp CCM 4824 expressed in recombinant strain E. coli BL21 CCM 7394 bearing the recombinant plasmid pKXIPl and processing of PA into biocatalyst useful for the industrial synthesis of antibiotics. More particularly the invention di...
ABSTRACT:
The invention discloses an improved cost-effective process for preparation of 7-Dehydrocholesterol of formula I with good yield and purity.
“A Nucleotide Sequence Encoding 7-Dehydrocholesterol Reductase, Recombinant Constructs And Recombinant Organisms Comprising Said Sequence”
ABSTRACT:
The present invneiton provides a novel nucleotide sequence represented by Seq ID No.1 encoding 7-dehydrocholesterol reductase (7-DHCR), recombinant DNA constructs ...
The present invention provides a stable and viable biocatalyst with high activity and operational stability and method of immobilization thereof. The immobilization process is based on the principle of entrapment of partially purified enzyme precipitate which is simultaneously aggregated by cross linking agent like ...
Disclosed herein macroporous polyvinyl acetate copolymer beads directly used to immobilize the lipase without any prior functional modification of beads and also discloses the process for preparation of said copolymer beads and the process of immobilizing the enzyme lipase.
Disclosed herein is acrylonitrile based macroporous terpolymer beads, for immobilization of enzymes to form immobilized enzyme catalyst and its subsequent application in enzymatic synthesis of semi-synthetic β-lactam antibiotics.
This invention discloses stable, highly porous and oxirane macro-porous beads with high enzyme expression abilities based on Glycidyl methacrylate- Ethylene glycol dimethacrylate-Divinyl benzene co-polymers and a novel process for the preparation of the said macro-porous polymer beads involving suspension polymeriza...
The invention consists in a nucleotide sequence having the size of (2646) bp, wherein the order of nucleotides is identical to the order of the nucleotide sequence encoding penicillin acylase from Achromobacter sp. CCM 4824 (formerly Comamonas testosteroni CCM 4824), eventually of the fragments of this sequence havi...
Disclosed herein is a process for synthesis of Molnupiravir from cytidine of using a lipase for esterification reaction. The process comprises of reacting compound of formula II with acetone in presence of sulphuric acid to obtain compound of formula III; enzymatically converting compound of Formula III to compound ...
The present invention discloses an improved catalytic process for the synthesis of 5-(3-pyridyl)-2, 2’-bithiophene in high yield and purity.
The present invention discloses novel method for synthesizing vegan 25-OH cholesterol/Calcifediol from inexpensive crude phytosterol. According to the method, Phytosterols are reacted to form corresponding i-steroid through tosylation and methanolysis. i-steroid on reductive ozonolysis to C-22 alcohol and conversion...
The present invention relates to a blended purified enzyme having origin of a mNPGA (mutant penicillin G acylase) from Achromobacter and Penicillin G acylase expressed in Escherichia coli. The present invention further relates to an immobilized blended purified enzyme and an enzymatic process for synthesis of semisy...
The invention discloses an improved process for production of vitamin D3 from 7- dehydrocholesterol (7- DHC) and to a simple process for recovery unreacted 7-DHC for further reuse. The invention further describes a process for isolation and purification of Vitamin D3.
The present invention discloses an improved photochemical synthesis of vitamin D3 from 7-dehydrocholesterol alone or in combination with sterol precursors in presence of the photosensitizer of Formula I in high yield and with reduced levels of impurities.
The present invention discloses an improved process for extracting cholesterol in high yield and purity from fish oil waste residue. The so obtained cholesterol of pharmaceutical grade is useful as a precursor for the preparation of vitamin D3.
The present invention discloses solvent free process for extracting cholesterol free of impurities from milk fat. The so isolated cholesterol is useful for the further preparation of vitamin D3. The present invention further provides pharmaceutical grade cholesterol from milk fat of high purity.
...
The present invention discloses an efficient process for synthesis of photosensitizer, 5-(3-pyridyl)-2,2"-bithiophene in high yield and purity.
Disclosed herein is a novel simple, short process for synthesis of the photosensitizer, 5-(3-pyridyl)-2,2"-bithiophene.
The present invention discloses novel method for synthesizing vegan cholesterol and vitamin D3 from inexpensive crude phytosterol.
Disclosed herein is an improved and efficient process for synthesis of vitamin D3 and its analogue Calcifediol from Ergosterol. Particularly, the present invention discloses the synthesis of key intermediate 3ß-tert-Butyldimethylsilyloxy-22-hydroxy-23,24-bisnorchola-5,7-diene (5), and novel intermediate ß-tert-Butyl...
The present invention discloses mutant semi-synthetic ß-lactam antibiotics synthesizing enzymes of penicillin G acylase from Achromobacter sp. CCM4824 generated by site directed mutations with substitution of one or more amino acid positions. The gene sequence encoding mutant penicillin acylase borne on plasmid pKAR...
The present invention provides a scalable two-step synthesis of molnupiravir. The reaction sequence involves the use of commercially easily available cytidine (1), and molnupiravir is formed through direct hydroxy amination of the cytidine followed by esterification of the primary alcohol without protecting dihydrox...
The present invention discloses a short, cost effective process for preparation of cholesterol from bisnoralcohol (BA).
The present invention discloses styrene butadiene rubber (SBR) composition containing the by-products based on renewable source such as calcium salt of lanolin fatty acid (CA), magnesium salt of lanolin fatty acids, pretreated calcium salt of lanolin fatty, lanolin fatty acids like crude (CLFA) and bleached lanolin ...
Disclosed herein is the enzymatic process for synthesis of Molnupiravir intermediate, 5’-isobutylester of cytidine acetonide. The process employs cytidine acetonide as starting material to prepare 5’-isobutylester of cytidine acetonide. The esterification of cytidine acetonide is carried out using Enzyme CAL B expre...
The present invention discloses an economical and improved, short process for synthesis of Molnupiravir from cytidine. The process of the present invention provides a novel intermediate N-Hydroxy Cytidine isobutyryl ester (13) which can be enzymatically converted to Molnupiravir in good yield and purity.
...
The present invention discloses an improved enzymatic synthesis of Sitalgiptin or its pharmaceutically acceptable salts in good yield and purity. The present invention provides novel intermediate (R)- 3-Acetamido-4-(2,4,5-Trifluorophenyl) butanoic acid (5).
The present invention discloses a process for conversion of bisnoralcohol into 7-DHC (provitamin of vitamin D3) and 25-OH 7-DHC (provitamin of 25-OH vitamin D3(Calcifediol), in good yields and purity.
The present invention discloses 25 Hydroxy Vitamin D3 1.25% spray dried feed composition for animals and to the process for preparation thereof.
The present invention relates to stable compositions of Cholecalciferol (Vitamin D3) and process of preparation thereof. The stable compositions of the present invention are obtained by spray drying of Vitamin D3 emulsion.
Disclosed herein is an improved, cost-effective scalable process for conversion of bisnoralcohol into 25-OH 7-DHC (provitamin of 25-OH vitamin D3(Calcifediol).
The present invention relates to lipase enzymes with enhanced activity titer by expressing a recombinant lipase gene at two different loci in a yeast host. The cultured lipase enzymes result in 2-4 fold expression of recombinant lipase activity per litre of culture media.
Disclosed herein is an industrially viable process for preparation of 7-dehycholesterol (7-DHC) from bisnoralcohol.
The present invention discloses plant based vitamin D3 (Cholecalciferol) that meets the pharmacopeia standard as well as “Green dot” specification. The present invention further discloses a commercial process for preparation of plant based vitamin D3 from plant sourced bisnoralcohol with improved yield and purity. T...
Registered Trademarks
[Class : 31] Fortified Food Substances For Animals; Animal Feed; Animal Feedstuffs; Animal Feed Preparations; Formula Animal Feed; Synthetic Animal Feed; Mixed Animal Feed; Fish Meal [Animal Feed]; Starch Pulp [Animal Feed]; Rice Bran [Animal Feed]; Soy Sauce Cakes [Animal Feed]; Soy Bean Meal [Animal Feed]; Preserved Crops For Animal Feeds; Foodstuffs Containing Phosphate ...
[Class : 5] Pharmaceuticals; Pharmaceutical Drugs; Pharmaceutical Preparations; Pharmaceutical Compositions; Injectable Pharmaceuticals; Chemical Preparation For Pharmaceutical Purposes; Nutraceuticals For Therapeutic Purposes; Nutraceutical Preparations For Therapeutic Or Medical Purposes; Nutraceuticals For Use As A Dietary Supplement; Nutritional Additives To Foodstuffs F...
[Class : 42] Chemical Research; Chemical Engineering; Chemical Laboratories; Chemical Analysis; Product Research And Development; Biochemical Research And Development; Scientific Research And Development; Pharmaceutical Research And Development; Research And Development Services; Biochemical Research And Development Services; Vaccine Research And Development Services; Resear...
View +80 more Brands for Fermenta Biotech Limited.
Charges
16 July 2012
Siemens Financial Services Private Limited
3 Crore
17 July 2014
Siemens Financial Services Private Limited
90 Lak
30 August 2018
Union Bank Of India
3 Crore
26 July 2016
Dbs Bank Ltd
1 Crore
30 March 2007
Union Bank Of India
4 Crore
15 October 2007
Union Bank Of India
1 Crore
06 July 2011
Union Bank Of India
2 Crore
21 March 2011
Union Bank Of India
2 Crore
06 April 2006
Icici Bank Ltd
1 Crore
07 February 1990
The British Bank Of The Middle Best
50 Lak
12 December 1989
Industrial Finance Co. Of India
50 Lak
26 December 1988
Industrial Finance Co. Of India
1 Crore
27 November 1987
Ifci
45 Lak
26 December 1988
Industrial Finance Corp. Of India
1 Crore
27 November 1987
Industrial Finance Co. Of Indiaq
45 Lak
28 November 1987
Himachal Pradesh State Industrial Deve. Co. Ltd.
90 Lak
20 March 1989
Industrial Finance Co. Of India Ltd.
25 Lak
19 July 1989
The British Bank Of The Middle Best
3 Crore
26 July 2016
Dbs Bank Ltd
0
30 August 2018
Others
0
30 March 2007
Union Bank Of India
0
20 March 1989
Industrial Finance Co. Of India Ltd.
0
28 November 1987
Himachal Pradesh State Industrial Deve. Co. Ltd.
0
26 December 1988
Industrial Finance Corp. Of India
0
27 November 1987
Industrial Finance Co. Of Indiaq
0
06 July 2011
Union Bank Of India
0
06 April 2006
Icici Bank Ltd
0
19 July 1989
The British Bank Of The Middle Best
0
26 December 1988
Industrial Finance Co. Of India
0
12 December 1989
Industrial Finance Co. Of India
0
15 October 2007
Union Bank Of India
0
17 July 2014
Siemens Financial Services Private Limited
0
16 July 2012
Siemens Financial Services Private Limited
0
27 November 1987
Ifci
0
21 March 2011
Union Bank Of India
0
07 February 1990
The British Bank Of The Middle Best
0
26 July 2016
Dbs Bank Ltd
0
30 August 2018
Others
0
30 March 2007
Union Bank Of India
0
20 March 1989
Industrial Finance Co. Of India Ltd.
0
28 November 1987
Himachal Pradesh State Industrial Deve. Co. Ltd.
0
26 December 1988
Industrial Finance Corp. Of India
0
27 November 1987
Industrial Finance Co. Of Indiaq
0
06 July 2011
Union Bank Of India
0
06 April 2006
Icici Bank Ltd
0
19 July 1989
The British Bank Of The Middle Best
0
26 December 1988
Industrial Finance Co. Of India
0
12 December 1989
Industrial Finance Co. Of India
0
15 October 2007
Union Bank Of India
0
17 July 2014
Siemens Financial Services Private Limited
0
16 July 2012
Siemens Financial Services Private Limited
0
27 November 1987
Ifci
0
21 March 2011
Union Bank Of India
0
07 February 1990
The British Bank Of The Middle Best
0
Documents
Form DPT-3-15102019-signed
Form DPT-3-14102019-signed
Form INC-28-01102019-signed
Copy of court order or NCLT or CLB or order by any other competent authority.-26092019
Optional Attachment-(2)-26092019
Optional Attachment-(4)-26092019
Optional Attachment-(3)-26092019
Optional Attachment-(1)-26092019
Form BEN - 2-19092019_signed
Declaration under section 90-19092019
Optional Attachment-(2)-19092019
Form CHG-1-19092019_signed
Optional Attachment-(3)-19092019
Instrument(s) of creation or modification of charge;-19092019
Optional Attachment-(1)-19092019
CERTIFICATE OF REGISTRATION OF CHARGE-20190919
Form MSME FORM I-18092019_signed
Form INC-28-11092019-signed
Optional Attachment-(1)-06092019
List of share holders, debenture holders;-06092019
Copy of MGT-8-06092019
Form MGT-7-06092019_signed
Copy of MGT-8-05092019
List of share holders, debenture holders;-05092019
Optional Attachment-(1)-05092019
Form MGT-7-05092019_signed
Copy of court order or NCLT or CLB or order by any other competent authority.-03092019
XBRL financial statements duly authenticated as per section 134 (including Board's report,auditor's report and other documents)-06082019
Statement of subsidiaries as per section 129-Form AOC-1 (To be attached in respect of Foreign subsidiaries)-06082019
XBRL document in respect Consolidated financial statement-06082019
